sunitinib
UkraineDrugs containing this active substance
-
The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), adjuvant therapy for RCC, as well as progressive neuroendocrine tumors of the pancreas.
Form: capsules
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
Manufacturer: Eugia Pharma Specialities Limited
-
The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), adjuvant therapy for RCC, as well as progressive pancreatic neuroendocrine tumors.
Form: capsules
Active substance Dosage sunitinib 50 mg ATC: L01EX01
Manufacturer: Eugia Pharma Specialities Limited
-
The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), adjuvant therapy for RCC, as well as progressive neuroendocrine tumors of the pancreas.
Form: capsules, hard gelatin
Active substance Dosage sunitinib 25 mg ATC: L01EX01
Manufacturer: Shilpa Medica Limited
-
The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), adjuvant therapy for RCC, as well as progressive neuroendocrine tumors of the pancreas.
Form: capsules, hard gelatin
Active substance Dosage sunitinib 37.5 mg ATC: L01EX01
Manufacturer: Shilpa Medica Limited
-
The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), adjuvant therapy for RCC, as well as progressive neuroendocrine tumors of the pancreas.
Form: capsules, hard gelatin
Active substance Dosage sunitinib 50 mg ATC: L01EX01
Manufacturer: Shilpa Medica Limited
-
The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), adjuvant therapy for RCC, as well as progressive neuroendocrine tumors of the pancreas.
Form: capsules, hard gelatin
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
Manufacturer: Shilpa Medica Limited
-
The drug is used to treat adults with unresectable or metastatic gastrointestinal stromal tumors (GIST), progressive or metastatic renal cell carcinoma (mRCC), as well as progressive unresectable or metastatic pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
Manufacturer: Teva Pharmaceutical Industries Ltd.
-
The drug is prescribed to adults for the treatment of unresectable or metastatic gastrointestinal stromal tumors (GIST), progressive or metastatic renal cell carcinoma (mRCC), as well as progressive unresectable or metastatic pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
Manufacturer: Teva Pharmaceutical Industries Ltd.
-
The drug is used to treat adults with unresectable or metastatic gastrointestinal stromal tumors (GIST), progressive renal cell carcinoma (RCC), and progressive pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
Manufacturer: Teva Pharmaceutical Industries Ltd.
-
The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), as well as for adjuvant therapy of RCC in patients at high risk of recurrence. It is also used for the treatment of progressive pancreatic neuroendocrine tumors.
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01XE04
Manufacturer: Remedika Ltd
-
The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), adjuvant therapy for adult RCC patients at high risk of recurrence after nephrectomy, and for the treatment of progressive pancreatic neuroendocrine tumors.
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01XE04
Manufacturer: Remedika Ltd
-
The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), adjuvant therapy for RCC in adults at high risk of recurrence, as well as progressive pancreatic neuroendocrine tumors.
Form: capsules, hard
Active substance Dosage sunitinib 37.5 mg ATC: L01XE04
Manufacturer: Remedika Ltd
-
The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), as well as adjuvant therapy for RCC in adults at high risk of recurrence after surgery. It is also used for the treatment of progressive pancreatic neuroendocrine tumors.
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01XE04
Manufacturer: Remedika Ltd
-
The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), adjuvant therapy for RCC after surgery, as well as progressive neuroendocrine tumors of the pancreas.
Form: capsules
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
Manufacturer: Pfizer Italia S.r.l.
-
The drug is used for the treatment of gastrointestinal stromal tumor (after disease progression or intolerance to other treatment), progressive renal cell carcinoma, adjuvant therapy for renal cell carcinoma after surgery, as well as for the treatment of progressive neuroendocrine tumors of the pancreas.
Form: capsules
Active substance Dosage sunitinib 25 mg ATC: L01EX01
Manufacturer: Pfizer Italia S.r.l.
-
The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), adjuvant therapy for RCC (for adults at high risk of recurrence after nephrectomy), as well as progressive neuroendocrine tumors of the pancreas.
Form: capsules
Active substance Dosage sunitinib 50 mg ATC: L01EX01
Manufacturer: Pfizer Italia S.r.l.
-
The drug is used for the treatment of gastrointestinal stromal tumor (after disease progression or intolerance to other treatment), progressive renal cell carcinoma, adjuvant therapy of renal cell carcinoma after surgery, as well as for the treatment of progressive neuroendocrine tumors of the pancreas.
Form: capsules
Active substance Dosage sunitinib 37.5 mg ATC: L01EX01
Manufacturer: Pfizer Italia S.r.l.
-
The drug is used for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), as well as for adjuvant therapy (prevention of recurrence) of RCC after surgery. It is also prescribed for the treatment of progressive neuroendocrine tumors of the pancreas.
Form: capsules, hard
Active substance Dosage sunitinib 37.5 mg ATC: L01XE04
Manufacturer: Synthon BV (batch release)
-
The drug is used for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), as well as for adjuvant therapy of RCC and the treatment of progressive neuroendocrine tumors of the pancreas.
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01XE04
Manufacturer: Synthon BV (batch release)
-
The drug is used for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), as well as for adjuvant therapy of RCC and the treatment of progressive neuroendocrine tumors of the pancreas.
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01XE04
Manufacturer: Synthon BV (batch release)
-
The drug is used for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), as well as neuroendocrine tumors of the pancreas. It is also used as adjuvant therapy for adults at high risk of RCC recurrence after surgery.
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01XE04
Manufacturer: Synthon BV (batch release)